Bactericidal composition containing tetramycin and Saisentong as well as preparation method and application of bactericidal composition

By using a dual-structure composite lignin derivative system and specific pH control, the instability and phytotoxicity problems of tetracycline and thiamethoxam compound preparations have been solved, achieving targeted release of active components and high-efficiency bactericidal effect, making it suitable for the prevention and control of citrus canker.

CN121970768APending Publication Date: 2026-05-05ZHEJIANG DONGFENG CHEM IND CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610413158.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-03-31
Publication Date
2026-05-05

AI Technical Summary

Technical Problem

In the existing technology, the combination of tetracycline and thiamethoxam has instability and phytotoxicity risk during storage and application, making it difficult to fully exert synergistic bactericidal activity, and copper ions are prone to causing phytotoxicity on tender citrus tissues.

Method used

A dual-structure composite lignin derivative system is used as a functional carrier, containing high molecular weight modified lignin sulfonate and low degree of polymerization specific lignin phenol fragments. This forms a physical barrier and triggers the targeted release of active components through extracellular enzymes. Combined with specific pH control, stability and safety are improved.

Benefits of technology

It improves the storage stability and crop surface adhesion of the formulation, reduces the risk of phytotoxicity, and achieves efficient release and concentrated action of active ingredients at the pathogen infection site, thus improving the control effect on citrus canker.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the field of pesticide preparations, and discloses a sterilization composition containing tetramycin and Saisentong as well as a preparation method and application of the sterilization composition. Tetramycin and Saisentong serve as active components of the composition, and a dual-structure composite lignin derivative system serves as a functional carrier; the system is composed of high-molecular-weight modified lignosulfonate and specific lignin phenol fragments with low polymerization degree. The high-molecular-weight component forms a physical barrier on the surfaces of active component particles, so that the storage stability and the application safety of the preparation are improved; the low-polymerization-degree component can be degraded by an extracellular enzyme secreted by citrus canker pathogen, so that the targeted release of the active component at the focus is realized. The composition disclosed by the invention effectively reduces the decomposition rate of the active components and the phytotoxicity risk to crops, and meanwhile, the field control effect on the citrus canker is remarkably improved. The composition provides an efficient and safe new choice with a targeting effect for chemical prevention and treatment of citrus canker.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pesticide formulation technology, and in particular to bactericidal compositions containing tetracycline and thiamethoxam, their preparation methods and applications. Background Technology

[0002] Citrus canker is a serious bacterial disease caused by Xanthomonas citri subsp. citri, posing a persistent threat to the global citrus industry. This disease infects citrus leaves, shoots, and fruit, leading to premature leaf drop, shoot dieback, and the formation of corky lesions, severely impacting the appearance and commercial value of the fruit, and even causing yield losses. Currently, chemical control remains one of the key measures to control the spread of citrus canker, with copper-based fungicides and antibiotic fungicides being the two main application categories.

[0003] Thiamethoxam, an organocopper fungicide, inhibits the activity of various enzymes in pathogens by releasing copper ions, exhibiting broad-spectrum and high efficacy. However, a common technical problem with conventional copper formulations is that excessive accumulation of free copper ions on crop surfaces can easily cause phytotoxicity to young citrus tissues (such as new shoots and young fruits), manifesting as scorched spots or growth inhibition. This limits its application concentration and frequency during critical growth stages. Furthermore, improper use of copper ions can also lead to environmental accumulation risks.

[0004] Tetracycline is an agricultural antibiotic with a unique mechanism of action. It inhibits bacterial growth by interfering with the synthesis of pathogen proteins, exhibits no cross-resistance with copper-based antibiotics, and has high crop safety. Theoretically, combining tetracycline with thiamethoxam could broaden the fungicidal spectrum, delay the development of resistance, and potentially achieve synergistic effects. However, combining these two chemically distinct active ingredients in the same formulation presents significant technical challenges. On one hand, the chemical structure of tetracycline is unstable under specific conditions (such as the presence of certain metal ions or unsuitable pH environments), making it prone to degradation and reduced efficacy. On the other hand, the direct contact between thiamethoxam and tetracycline in the formulation may lead to mutual interference, resulting in physical or chemical instability, stratification, and clumping, thereby reducing the product's storage stability and practical application effectiveness.

[0005] Therefore, developing a compound formulation that can fully utilize the synergistic bactericidal activity of tetracycline and thiamethoxam while overcoming their instability and phytotoxicity risks during storage and application is a technical challenge that urgently needs to be solved in the field of citrus canker control. Summary of the Invention

[0006] The technical problem to be solved by the present invention is to provide a bactericidal composition, its preparation method and application. Based on tetramycin and thiamethoxam, the composition solves the stability problem of the active component during the preparation storage and application process by introducing specific functional components and adopting specific processes, and constructs an active component release mechanism triggered by specific pathogens.

[0007] To solve the above-mentioned technical problems, the present invention provides the following technical solution:

[0008] The first aspect of the present invention provides a bactericidal composition.

[0009] The composition comprises the active components tetramycin and thiamethoxam, as well as a dual-structure complex lignin derivative system serving as a functional carrier. In the active components, the weight ratio of the active ingredients tetramycin to thiamethoxam is 1:1 to 1:30.

[0010] The dual-structure composite lignin derivative system consists of two components:

[0011] High molecular weight modified lignin sulfonate;

[0012] Low-polymerization-degree specific lignin phenolic fragments.

[0013] The preparation method of the low-polymerization-degree specific lignin phenolic fragment includes the following steps:

[0014] (1) Dissolve alkali lignin in an aqueous sodium hydroxide solution to prepare a lignin solution with a concentration of 5-15 g / L;

[0015] (2) Transfer the solution from step (1) to the reaction vessel, introduce oxygen under stirring to maintain the pressure inside the vessel at 0.5-1.5 MPa, and raise the temperature to 80-140℃.

[0016] (3) Under the above temperature and pressure conditions, react for 30-90 minutes to carry out controlled oxidative degradation;

[0017] (4) After the reaction is complete, cool to room temperature and adjust the pH value to 2.0-3.0 with acid to precipitate the high molecular weight fraction;

[0018] (5) Separate the precipitate by centrifugation or filtration and collect the supernatant;

[0019] (6) The supernatant is subjected to ultrafiltration to retain and collect fractions with a molecular weight of 500-2,000 g / mol. After drying, the low-polymerization-degree specific lignin phenol fragments are obtained.

[0020] The high molecular weight modified lignin sulfonate can be obtained by any of the following methods:

[0021] The preparation methods include selecting commercially available products that meet the requirements, or preparing them through fractional purification of industrial-grade lignin sulfonates, and the preparation methods include:

[0022] Using industrial sodium lignosulfonate or calcium lignosulfonate as starting materials, they are dissolved in water and then processed using ultrafiltration membrane separation technology.

[0023] By using an ultrafiltration membrane with a specific molecular weight cutoff (MWCO), for example, initially using an ultrafiltration membrane with a molecular weight cutoff of 15,000-20,000 g / mol, the retentate is collected to remove small molecule impurities;

[0024] The retained solution can then be further fractionated to separate and collect fractions with molecular weights mainly distributed in the range of 20,000-50,000 g / mol, which are then dried.

[0025] In one specific embodiment, the composition comprises, by weight percentage:

[0026] The total active ingredients (tetracycline and thiamethoxam) range from 15.0% to 40.0%.

[0027] The total content of the dual-structure complex lignin derivative system ranges from 3.0% to 15.0%.

[0028] Wetting agent 1.0%-5.0%;

[0029] Antifreeze 3.0%-8.0%;

[0030] Thickener 0.1%-0.5%;

[0031] And the remaining water.

[0032] In one specific embodiment, in the dual-structure composite lignin derivative system, the high molecular weight modified lignin sulfonate has a molecular weight of 20,000-50,000 g / mol; the low degree of polymerization specific lignin phenolic fragment has a molecular weight of 500-2,000 g / mol; and the weight ratio of the high molecular weight modified lignin sulfonate to the low degree of polymerization specific lignin phenolic fragment is 5:1 to 20:1.

[0033] In one specific embodiment, the composition is formulated as a water-based suspension. The final pH value of the water-based suspension is 5.5 to 6.5. The particle size distribution D90 value of the solid particles is 1 to 5 μm.

[0034] A second aspect of the present invention provides a method for preparing the bactericidal composition described in the first aspect.

[0035] The method includes the following steps:

[0036] (a) The active components tetramycin, thiamethoxam, and dual-structure complex lignin derivatives were pre-dispersed in water to form a slurry;

[0037] (b) The slurry from step (a) is wet-milled until the particle size distribution D90 value of the solid particles is 1 to 5 μm.

[0038] In one specific implementation, during the wet sand milling process in step (b), the cavity temperature is controlled within the range of 20 to 45°C by a cooling system.

[0039] In one specific embodiment, the method further includes a post-adjustment step after step (b). This post-adjustment step includes adjusting the final pH of the composition to 5.5 to 6.5 using a pH adjuster.

[0040] The third aspect of the present invention provides the use of the bactericidal composition described in the first aspect in the preparation of pesticide formulations for the prevention and control of citrus canker.

[0041] In this application, the bactericidal composition operates through the following process:

[0042] When the bactericidal composition is applied to the surface of citrus crops, it forms a continuous physical film composed of high molecular weight modified lignin sulfonate, which encapsulates the active components tetramycin and thiamethoxam, as well as low-polymerization specific lignin phenolic fragments.

[0043] When the citrus canker pathogen (Xanthomonas citri subsp. citri) colonizes and begins to infect the film surface, it secretes extracellular enzymes, including xylanase, cellulase, and laccase. These extracellular enzymes specifically recognize and degrade low-polymerization lignin phenolic fragments that serve as their substrates. This degradation process creates localized pores or structural discontinuities in the continuous physical film, disrupting its integrity. Water molecules and external environmental factors enter the film through these pores, causing the previously encapsulated active components, tetracycline and thiamethoxam, to diffuse out through these formed channels, thus creating regions of high concentration of active components at the sites of pathogen infection.

[0044] In summary, the present invention has at least one of the following beneficial technical effects:

[0045] 1. The bactericidal composition provided by this invention employs a dual-structure composite lignin derivative system as a functional carrier, wherein high molecular weight modified lignin sulfonate forms a physical barrier on the surface of the active ingredient particles. This structure effectively isolates tetracycline and thiamethoxam, inhibiting potential degradation or physical state changes of both during formulation storage, thus improving the storage stability of the composition. Simultaneously, this structure enhances the adhesion of the agent to the crop surface after application, reducing the loss of active ingredients due to environmental factors.

[0046] 2. The technical solution of this invention controls the final pH value of the composition within the range of 5.5 to 6.5, ensuring that the active component tetracycline is within its chemically stable pH range, while thiamethoxam poses a lower potential phytotoxic risk to crops under these pH conditions. Combined with the sustained-release effect of the functional carrier on copper ions, this composition improves the safety of application to crops, especially young tissues, while ensuring bactericidal activity.

[0047] 3. The bactericidal composition of this invention utilizes the characteristic that low-polymerization-degree specific lignin phenolic fragments can be degraded by extracellular enzymes secreted by *Citrus canker*. This design inhibits the release of the active ingredient in the absence of pathogens, but triggers it at the site of pathogen infection, achieving concentrated release of the active ingredient at the lesion. This targeted release mechanism allows limited active ingredients to act concentratedly on the target pathogen, thereby improving the control effect against the target disease. Detailed Implementation

[0048] To make the objectives, technical solutions, and advantages of this invention clearer, the technical solutions of this invention will be clearly and completely described below in conjunction with embodiments. Obviously, the described embodiments are merely some embodiments of this invention, and not all embodiments. Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this invention.

[0049] Preparation example:

[0050] The present invention provides a method for preparing specific lignin phenolic fragments with low degree of polymerization, the steps of which are as follows:

[0051] Weigh 100 g of alkali lignin and dissolve it in 10 L of 0.2 mol / L sodium hydroxide aqueous solution to prepare a lignin solution with a concentration of 10 g / L.

[0052] The solution was transferred to a 20 L reactor, and oxygen was introduced at a stirring rate of 500 rpm until the pressure inside the reactor reached 1.0 MPa, while the temperature inside the reactor was raised to 120 °C.

[0053] The reaction was maintained at 120°C and 1.0 MPa for 60 minutes.

[0054] After the reaction was completed, the reaction solution was cooled to room temperature, and 6 mol / L hydrochloric acid was added dropwise to adjust the pH of the solution to 2.5. At this point, a solid precipitate was observed to form.

[0055] Centrifuge the mixture at 8000 rpm for 15 minutes, carefully separate and collect the supernatant.

[0056] The supernatant was treated with an ultrafiltration membrane with a molecular weight cutoff of 2,000 Da, and the filtrate was collected. The collected filtrate was then treated with an ultrafiltration membrane with a molecular weight cutoff of 500 Da, and the filtrate was collected.

[0057] The final collected retention solution was freeze-dried to obtain a brown powdery product of low-polymerization degree specific lignin phenolic fragments for later use.

[0058] To further illustrate the present invention, the following examples provide specific formulations and preparation methods for the bactericidal compositions of the present invention. The high molecular weight modified lignin sulfonate used in the following examples was obtained by ultrafiltration fractionation purification of commercially available industrial sodium lignin sulfonate, with a weight-average molecular weight of 35,000 g / mol. The low-polymerization degree specific lignin phenolic fragments used in the following examples were prepared using the aforementioned method.

[0059] Table 1. Formulations of the compositions in Examples 1-3 (unit: weight %):

[0060] Component Name Example 1 Example 2 Example 3 Tetracycline (90% technical grade) 4 1.5 10 Thiamethoxam (95% technical grade) 38.3 30.15 11.58 High molecular weight modified lignin sulfonate 7.2 10 5.7 Low-polymerization degree specific lignin phenolic fragments 0.8 1 0.3 Nonylphenol polyoxyethylene ether 3 2 4 Ethylene glycol 5 6 4 Xanthan Gum 0.2 0.25 0.3 polydimethylsiloxane 0.5 0.6 0.4 Deionized water 41 48.5 63.72 total 100 100 100

[0061] The compositions of Examples 1 to 3 above were all obtained by the following general preparation process:

[0062] (a) Preparation of pre-dispersed slurry: According to the formulation amounts in Table 1, weigh all the required amounts of deionized water, ethylene glycol, nonylphenol polyoxyethylene ether, and polydimethylsiloxane into a mixing tank. Start high-speed shear stirring at 1200 rpm to mix all materials evenly. Then, add the required amounts of high molecular weight modified lignin sulfonate and low-polymerization degree specific lignin phenolic fragments, and stir for 15 minutes to ensure thorough dispersion. While maintaining stirring, slowly add the required amounts of tetracycline technical and thiamethoxam technical. After the addition is complete, continue high-speed shear stirring for 30 minutes to form a uniform primary slurry.

[0063] (b) Wet milling: The primary slurry prepared in step (a) is pumped into a horizontal mill. This mill uses zirconia beads with a diameter of 0.8-1.0 mm as the grinding media, with a media filling rate of 85%. The cooling jacket is activated to control the milling chamber temperature below 35°C, and the spindle speed is set to 12 m / s. The slurry is circulated during milling, with periodic sampling and particle size analysis using a laser particle size analyzer. Milling is stopped and the material is discharged when the particle size distribution D90 value is less than 3 μm.

[0064] (c) Post-blending: Transfer the qualified milled material to a post-blending tank. Pre-wet the xanthan gum of the prescribed amount with a small amount of water to prepare a 2% stock solution. Slowly add the xanthan gum stock solution to the material while stirring at a low speed of 200 rpm, and continue stirring for 60 minutes to allow the system to thicken uniformly. Adjust the pH of the final product to 6.0 using a 1 mol / L citric acid aqueous solution. Filter and package the material to obtain the finished products of Examples 1-3.

[0065] Comparative Example 1:

[0066] Compared with Example 1, the difference is that it does not contain high molecular weight modified lignin sulfonate and low degree of polymerization specific lignin phenol fragments, the weight of which is made up by deionized water, and the other components and preparation methods are the same.

[0067] Comparative Example 2:

[0068] Compared with Example 1, the difference is that it does not contain high molecular weight modified lignin sulfonate and low degree of polymerization specific lignin phenol fragments, but instead uses an equal weight (8.0%) of commercially available sodium lignin sulfonate (CAS: 8061-51-6) as a conventional dispersant. The other components and preparation methods are the same.

[0069] Comparative Example 3:

[0070] Compared with Example 1, the difference is that it does not contain low-polymerization degree specific lignin phenolic fragments, the weight of which is made up by high molecular weight modified lignin sulfonate (i.e., the total addition amount of high molecular weight modified lignin sulfonate is 8.0%), and the other components and preparation methods are the same.

[0071] Comparative Example 4:

[0072] This comparative example is a tank-mixed combination of commercially available single-dose formulations. Its composition is as follows: 4% tetracycline suspension and 40% thiamethoxam suspension are directly mixed and diluted with water before use, so that the weight ratio of the active ingredients of tetracycline to thiamethoxam in the mixed solution is the same as in Example 1.

[0073] Test Example 1: Thermal Storage Stability Test

[0074] This test case aims to evaluate the physical and chemical stability of the compositions of Examples 1-3 and Comparative Examples 1-3 under accelerated aging conditions.

[0075] The testing steps are as follows:

[0076] (1) Sampling: Take two samples, each about 50 mL, from the finished products of Examples 1-3 and Comparative Examples 1-3, and label them as the initial sample and the storage sample, respectively.

[0077] (2) Heat storage treatment: All samples marked as storage samples were sealed in 100 mL stoppered glass bottles and placed in a constant temperature oven at 54±2℃ for 14 consecutive days. After 14 days, they were taken out and cooled to room temperature (25±2℃) for use.

[0078] (3) Determination of active ingredient content: Accurately weigh approximately 0.5 g of the initial sample and the stored sample, respectively. The content of tetracycline was determined using high performance liquid chromatography (HPLC), and the content of thiamethoxam (calculated as copper element) was determined using atomic absorption spectrometry (AAS). Based on the changes in content before and after heat storage, the decomposition rate of each active ingredient was calculated. Decomposition rate (%) = [(content before storage - content after storage) / content before storage] × 100.

[0079] (4) Suspension rate determination: The suspension rate of the stored sample was determined according to the standard method of GB / T 14825-2023. The sample was placed in a 30℃ water bath, the solution was prepared with standard hard water, and the sample was measured after standing for 30 minutes.

[0080] The test results are shown in Table 2:

[0081] Table 2: Decomposition rate and suspension rate of effective components in each treatment group after thermal storage:

[0082] Processing group Tetracycline decomposition rate (%) Thiamine copper decomposition rate (%) Suspension rate (%) Example 1 1.9 2.3 91.3 Example 2 2.5 2.8 89.1 Example 3 2.1 2.6 90.5 Comparative Example 1 13.8 15.2 45.7 Comparative Example 2 8.1 9.5 68.4 Comparative Example 3 5.4 6.8 81.6

[0083] According to the experimental data in Table 2, after being stored at 54°C for 14 days, the compositions of Examples 1, 2, and 3 showed decomposition rates of the active components tetramycin and thiamethoxam below 3.0%, and suspension rates above 89.0%. In contrast, Comparative Example 1, which did not contain any functional carrier, showed decomposition rates of both active components exceeding 13.0%, and a suspension rate reduced to 45.7%. Comparative Example 2, which used conventional sodium lignin sulfonate, and Comparative Example 3, which used only high molecular weight modified lignin sulfonate, showed worse decomposition and suspension rates than Examples 1, 2, and 3.

[0084] Data shows that the dual-structure composite lignin derivative system in the composition of this invention can effectively maintain the chemical stability and physical dispersibility of the active component in the formulation. The high molecular weight modified lignin sulfonate in this system forms a physical adsorption layer on the surface of the active component particles. This adsorption layer, through steric hindrance, prevents irreversible aggregation of solid particles due to Brownian motion, thereby maintaining a high suspension rate of the system. Simultaneously, this physical adsorption layer also isolates the tetramycin and thiamethoxam particles from direct contact, inhibiting potential catalytic degradation between them, resulting in a lower decomposition rate of the active component.

[0085] The data from Comparative Example 3 show that while using high molecular weight modified lignin sulfonate alone can provide some stability, its active component decomposition rate is still significantly higher than that of Examples 1, 2, and 3. This indicates that the presence of low-polymerization-degree specific lignin phenolic fragments is necessary. This low molecular weight component can fill the gaps between the adsorption layers of the high molecular weight component or interact with it, forming a more dense and complete composite protective layer. This composite layer further enhances the coating effect on the active component particles, thereby minimizing the degradation rate of the active component under thermal storage conditions.

[0086] Test Example 2: Crop Safety Trial

[0087] This test case aims to evaluate the effects of the compositions of Examples 1-3 and Comparative Examples 1-3 on young citrus tissues under overdose conditions.

[0088] The testing steps are as follows:

[0089] (1) Experimental preparation: Select citrus seedlings with uniform growth and 3-4 undeveloped new shoots in pots.

[0090] (2) Preparation of drug solution: The formulation samples of Examples 1-3 and Comparative Examples 1-3 were diluted 500 times with deionized water, which is twice the conventionally recommended concentration. A blank control was set up with distilled water.

[0091] (3) Application treatment: Using a handheld sprayer, the prepared solution was evenly sprayed onto the leaves of citrus seedlings in each treatment group until both sides of the leaves were completely wetted and a small amount of liquid dripped down. Each treatment was repeated 3 times and arranged randomly.

[0092] (4) Observation and Recording: After treatment, all seedlings were placed in a normal growing environment. On the 3rd, 7th, and 14th days after application, the leaves of each treatment group were visually inspected and the symptoms of scorching spots, yellowing, curling, or deformity were recorded. Based on the leaves with the most severe symptoms, the phytotoxicity was graded according to the following standards: Grade 0, no visible phytotoxicity symptoms; Grade 1, very slight spots or yellowing on the leaves, with an affected area of ​​less than 5%; Grade 2, obvious spots or yellowing on the leaves, with an affected area of ​​5%-15%; Grade 3, scorched patches or curling on the leaves, with an affected area of ​​16%-30%; Grade 4, severely scorched or fallen leaves, with an affected area of ​​more than 30%.

[0093] The test results are shown in Table 3:

[0094] Table 3: Assessment of pesticide damage levels in citrus seedlings 14 days after application:

[0095] Processing group Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Water comparison Phytotoxicity level 0 1 0 4 3 2 0

[0096] According to the experimental data in Table 3, 14 days after application, no phytotoxicity symptoms were observed in the treatments of Examples 1 and 3, with a phytotoxicity level of 0; Example 2 showed very slight phytotoxicity symptoms, with a phytotoxicity level of 1. Comparative Example 1 showed severe leaf burn and partial leaf drop, with a phytotoxicity level of 4. Comparative Examples 2 and 3 showed obvious burn patches and spots, with phytotoxicity levels of 3 and 2, respectively. The water control group showed no abnormalities.

[0097] Data shows that the formulation structure of the composition described in this invention can significantly reduce the risk of phytotoxicity to young citrus tissues from the active ingredient, particularly thiamethoxam. This is because the dual-structure composite lignin derivative system effectively encapsulates the thiamethoxam particles. This composite coating layer acts as a physical barrier, regulating the release rate of copper ions on the leaf surface and preventing the formation of high concentrations of free copper ions shortly after application, thereby reducing damage to plant cells. Simultaneously, controlling the pH of the formulation within a weakly acidic range of 6.0 also keeps the form and activity of copper ions in a state that is relatively mild for plant tissues.

[0098] Comparative Example 1, lacking any functional carrier coating, experienced rapid release of copper ions, resulting in the highest level of phytotoxicity. In Comparative Example 2, the conventional sodium lignosulfonate dispersant had limited ability to regulate copper ion release and failed to effectively reduce phytotoxicity. Comparative Example 3, using only high molecular weight components, achieved some coating, but its phytotoxicity level was still higher than the examples. This indicates that a dual-structure composite system composed of both high and low molecular weight fragments can form a more complete and stable coating layer, thereby effectively controlling copper ion release and ultimately demonstrating crop safety.

[0099] Test Example 3: Field efficacy trial of pesticides for controlling citrus canker

[0100] This test case aims to evaluate the control efficacy of the compositions of Examples 1-3 and Comparative Examples 1-4 against citrus canker under natural disease conditions in the field.

[0101] The testing steps are as follows:

[0102] (1) Experimental site and setup: The experiment was conducted in an orchard where citrus canker is a common disease. Citrus trees of similar age, vigor, variety, and degree of damage were selected as experimental subjects. Treatment groups included Examples 1-3, Comparative Examples 1-4, and a water control group. The experiment adopted a randomized block design, with each treatment replicated 4 times and 3 trees per plot.

[0103] (2) Application method: The first application of pesticide was carried out during the new shoot stage of citrus, at the initial stage of canker disease (when lesions are first observed in the field). All pesticide treatment groups were sprayed evenly on the plants using a backpack sprayer at a concentration of 1000 times dilution, until both sides of the leaves were completely wetted. The second application was carried out 10 days after the first application.

[0104] (3) Disease survey: Fourteen days after the last application of pesticide, a disease survey was conducted in each plot. For each plot, branches from the upper and middle parts of the east, south, west, and north directions were randomly selected. Twenty new leaves were surveyed from each direction, for a total of 80 leaves, and the number of lesions at each level was recorded. The disease grading standards were: Grade 0, no lesions; Grade 1, lesions covering less than 5% of the leaf area; Grade 3, lesions covering 6%-15% of the leaf area; Grade 5, lesions covering 16%-25% of the leaf area; Grade 7, lesions covering 26%-50% of the leaf area; Grade 9, lesions covering more than 50% of the leaf area.

[0105] (4) Data calculation: Calculate the disease index and prevention and control effect based on the survey results.

[0106] Disease index = [Σ(number of diseased leaves at each level × relative level value) / (total number of leaves surveyed × highest level value)] × 100;

[0107] Prevention and control effect (%) = [(disease index of control group - disease index of treatment group) / disease index of control group] × 100.

[0108] The test results are shown in Table 4:

[0109] Table 4: Results of field efficacy trials for controlling citrus canker:

[0110] Processing group Disease index Prevention and control effect (%) Example 1 8.2 89.1 Example 2 10.2 86.5 Example 3 6.6 91.2 Comparative Example 1 56.2 25.3 Comparative Example 2 33.3 55.8 Comparative Example 3 20.8 72.4 Comparative Example 4 36.4 51.6 Water comparison 75.3 0

[0111] According to the experimental data in Table 4, the control efficacy of treatment groups 1, 2, and 3 against citrus canker ranged from 86.5% to 91.2%. In contrast, the control efficacy of all comparative treatment groups was significantly lower than that of the example treatment groups. Among them, Comparative Example 1, which did not contain any functional carrier, and Comparative Example 4, which contained a commercially available single-agent tank mix, had control efficiencies of 25.3% and 51.6%, respectively. Comparative Example 2, which used a conventional dispersant, and Comparative Example 3, which contained only high molecular weight components, had control efficiencies of 55.8% and 72.4%, respectively, both lower than those of the example treatment groups.

[0112] Data shows that the structural design of the composition described in this invention can improve the control effect against citrus canker. In this composition, a dual-structure composite lignin derivative system encapsulates the active components, forming a thin film after application to the crop surface. The low-polymerization degree specific lignin phenolic fragments in this film structure can serve as degradation substrates for extracellular enzymes secreted by the citrus canker pathogen. At the pathogen infection site, the enzymatic degradation process causes local structural damage to the film, forming microchannels, thereby releasing the encapsulated tetracycline and thiamethoxam active components.

[0113] This process allows the active component to reach a high concentration at specific sites where the pathogen exists, thereby achieving effective inhibition of the pathogen. Comparative Example 3 contains only a high molecular weight component and lacks this pathogen-triggered release mechanism; the release of its active component mainly relies on passive diffusion, therefore its control effect is lower than that of the examples. Comparative Examples 1, 2, and 4 completely lack this pathogen-targeting release mechanism; the active component is rapidly diluted or lost in the environment, resulting in the lowest control effect. This result confirms that the synergistic effect of the two components in the described dual-structure system is the reason for the higher control effect.

[0114] Test Example 4: Comparison of in vitro antibacterial activity between the composition of the present invention and a simple mixed formulation

[0115] This test case aims to compare the in vitro inhibitory activity of the finished formulation of Example 1 of the present invention with that of Comparative Example 4 (a simple physical mixture of the active ingredients) against Citrus canker pathogen (Xcc) in order to evaluate the effect of the formulation structure of the present invention on the final biological activity.

[0116] Test method:

[0117] (1) Test reagents:

[0118] Group A: The finished formulation of Example 1 of this invention.

[0119] Group B: Comparative Example 4, which is to directly mix commercially available 4% tetracycline suspension and 40% thiamethoxam suspension before use, according to the proportion of the active ingredients in Example 1.

[0120] (2) Test method: The test method is in accordance with NY / T 1156.16-2008 "Guidelines for Indoor Bioassay Tests of Pesticides - Part 16: Test for Inhibition of Bacterial Growth - Turbidity Method".

[0121] (3) Concentration setting: The drugs in groups A and B were diluted with sterile water containing 0.1% Tween-80. The dilution concentration series was set based on the total concentration of the active ingredient to ensure that groups A and B had exactly the same tetracycline and thiamethoxam content at each concentration point. According to the preliminary test, the total concentration series of the active ingredient was set as follows: 1.25, 2.5, 5.0, 10.0, 20.0, 40.0 mg / L.

[0122] (4) Data processing: The same method as in the combined toxicity test report was used to determine OD after 24 hours of incubation. 600 The growth inhibition rate was calculated, and statistical analysis was performed using DPS software to calculate the EC50 values ​​for each treatment. 50 value.

[0123] Table 5: Virulence test results of Example 1 and Comparative Example 4 against *Citrus canker*:

[0124] Processing group virulence regression equation Correlation coefficient (r) EC50 value (mg / L) 95% confidence limit for EC50 (mg / L) Example 1 y = 2.158x + 3.109 0.988 7.96 6.55-9.14 Comparative Example 4 y = 1.992x + 2.871 0.985 11.53 9.89-13.02

[0125] According to the data in Table 5, the EC50 value of the product of Example 1 was 7.96 mg / L, while the EC50 value of Comparative Example 4 (simple tank mix) was 11.53 mg / L. With the same type and content of active ingredients, the EC50 value of Example 1 was significantly lower than that of Comparative Example 4.

[0126] These results demonstrate that the formulation structure of the present invention itself can improve the bioavailability or antibacterial effect of the active ingredient. This is attributed to the effective encapsulation and dispersion of the active ingredient particles by the dual-structure composite lignin derivative system. This structure allows the active ingredient particles to exist in the culture medium with a smaller particle size and a more stable state, increasing the contact surface area with pathogen cells, thereby exhibiting higher inhibitory activity at the same active ingredient concentration.

[0127] Test Example 5: In vitro validation test of the targeted release mechanism of the composition

[0128] This test case aims to verify, through simulation experiments, the mechanism by which low-polymerization-degree specific lignin phenolic fragments in the composition of the present invention are degraded in the presence of pathogens, thereby triggering the release of active components.

[0129] Test method:

[0130] (1) Test reagents and treatments:

[0131] Group A (Direct Action Group): The finished formulation from Example 1 was added to a solution containing Citrus canker pathogens (10... 7 cfu·mL -1 In NB medium.

[0132] Group B (simulated release group): The finished formulation from Example 1 was added to sterile NB medium and cultured with shaking at 24°C and 120 rpm for 4 hours. After culture, the mixture was centrifuged at 10,000 rpm for 10 minutes under sterile conditions, and the supernatant was collected. Then, *Citrus canker* (10...) was inoculated into the supernatant. 7 cfu·mL -1 ).

[0133] Group C (control release group): Comparative Example 3 (without low-polymerization lignin fragments) was treated in the same way as Group B, and the supernatant was taken and inoculated with pathogens.

[0134] (2) Concentration setting: The initial amount of reagent added to all treatment groups was kept the same, so that the total concentration of the theoretical effective ingredient was 10 mg / L.

[0135] (3) Data collection: After inoculation with the pathogen, all treatment groups were cultured at 24℃ and 120 r / min for 24 hours with shaking, and then their OD was measured. 600 The values ​​were compared with a blank control group that did not contain any drugs, and the growth inhibition rate was calculated.

[0136] Table 6: Growth inhibition rate of *Citrus canker* under different treatments:

[0137] Processing group Initial potion Handling method Growth inhibition rate (%) Group A Example 1 Direct mixing of medicine and pathogens for culture 68.7 Group B Example 1 After pre-culturing with the drug, the supernatant was used. 11.3 Group C Comparative Example 3 After pre-culturing with the drug, the supernatant was used. 15.1 Blank control - Bacterial culture only 0

[0138] According to the data in Table 6, Group A (direct interaction between the agent and the pathogen) showed the highest growth inhibition rate, reaching 68.7%. In Group B, after pre-culturing the formulation of Example 1 in sterile medium, the supernatant showed a growth inhibition rate of only 11.3% against the pathogen, indicating that in the absence of pathogens, the amount of active ingredient passively released from the formulation particles into the culture medium is very limited. The inhibition rate of Group C (supernatant of Comparative Example 3) was similar to that of Group B, also at a low level.

[0139] This result confirms the mechanism of action of the composition of the present invention. In group A, extracellular enzymes secreted by *Citrus canker* degraded low-polymerization lignin phenolic fragments on the surface of the formulation particles, disrupting the structural integrity of the coating layer and leading to the effective release of the internal active components, thereby producing a significant inhibitory effect. In groups B and C, due to the lack of the triggering condition of pathogen enzymatic hydrolysis, most of the active components remained bound within the formulation particles and did not enter the supernatant; therefore, the antibacterial activity of the supernatant was extremely low. This experiment verifies in vitro that the composition possesses targeted release characteristics triggered by pathogen activity.

[0140] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A bactericidal composition, characterized in that, It contains the active components tetramycin and thiamethoxam, as well as a dual-structure complex lignin derivative system that serves as a functional carrier. In the active components, the weight ratio of tetramycin to thiamethoxam is (1:1) to (1:30). The dual-structure composite lignin derivative system consists of high molecular weight modified lignin sulfonate and low-polymerization degree specific lignin phenolic fragments.

2. The bactericidal composition according to claim 1, characterized in that, The composition comprises, by weight percentage: The total active ingredient content is 15.0%–40.0%; The total content of the dual-structure complex lignin derivative system ranges from 3.0% to 15.0%. Wetting agent 1.0%~5.0%; Antifreeze 3.0%–8.0%; Thickener 0.1%–0.5%; The remaining water.

3. The bactericidal composition according to claim 1, characterized in that, In the dual-structure composite lignin derivative system: The high molecular weight modified lignin sulfonate has a molecular weight of 20,000 to 50,000 g / mol. The molecular weight of the low-polymerization-degree specific lignin phenolic fragment is 500–2,000 g / mol; The weight ratio of the high molecular weight modified lignin sulfonate to the low degree of polymerization specific lignin phenolic fragment is (5:1) to (20:1).

4. The bactericidal composition according to claim 1, characterized in that, The composition is formulated as a water-based suspension with a final pH of 5.5 to 6.

5.

5. The bactericidal composition according to claim 1, characterized in that, The composition is a water-based suspending agent, wherein the particle size distribution D90 value of the solid particles is 1-5 μm.

6. A method for preparing the bactericidal composition according to any one of claims 1-5, characterized in that, Includes the following steps: (a) The active components tetramycin, thiamethoxam, and dual-structure complex lignin derivatives were pre-dispersed in water to form a slurry; (b) The slurry from step (a) is wet-milled until the particle size distribution D90 value of the solid particles is 1 to 5 μm.

7. The preparation method according to claim 6, characterized in that, During the wet sand milling process in step (b), the chamber temperature is controlled at 20–45°C by a cooling system.

8. The preparation method according to claim 6, characterized in that, The method further includes a post-blending step after wet milling, which includes adjusting the final pH of the composition to 5.5–6.5 using a pH adjuster.

9. The use of the bactericidal composition according to any one of claims 1-5 in the preparation of a pesticide formulation for the prevention and control of citrus canker.

10. The application according to claim 9, characterized in that, When the bactericidal composition is applied to the surface of citrus crops, it can target and release the active components tetramycin and thiamethoxam under the action of extracellular enzymes secreted by citrus canker pathogens.